When it comes to your care, you expect the best. That’s why our cancer team prides itself not just on our DeLand hospital, but on our connections to the leading cancer care experts in Volusia County. We don’t stop with current options. You'll have access to more national clinical trials than any other oncology practice in Florida.
Some of our leading cancer diagnostic and treatment technologies include:
- 3D Simulation Treatment Planning — Uses advanced technology to visualize the tumor and create the best plan for treatment
- 4D CT Simulation — Helps us see your tumor and healthy tissues through a moving video, allowing us to create a better treatment plan
- Brachytherapy — A treatment that involves placing tiny bits of radiation directly near the source of cancer
- Eclipse Treatment Planning System — Helps us plan your radiation doses by taking scans of your tumor in three dimensions
- Image-Guided Radiation Therapy (IGRT) — The most advanced form of radiation available, allowing for the most precise tumor visualization possible
- Immunotherapies — Target cancer at the molecular level
- Intensity Modulated Radiation Therapy (IMRT) — Combined with Rapid Arc, this delivers high doses of targeted radiation to help keep non-cancerous tissue healthy
- PET CT — Simulations that take a closer look at cancer cells that may be hidden, allowing for more accurate tumor targeting
- Rapid Arc — Cutting edge technology that combines shorter treatment time for the highest level of patient comfort, with IMRT technology for fewer side effects than standard radiation therapy.
- Stereotactic Radiation — A leading-edge and targeted high-dose radiation treatment that helps reduce treatment time
We also have a 48-hour appointment guarantee, and work to get all lab tests back to you within 24 hours, because time is important. Our Aria software system also records your medical history, nursing assessments, imaging reports, prescriptions, and cancer treatments, so every person on your team can work collaboratively and efficiently together.